ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Scientifically-designed fasting diet lowers risks for major diseases

More evidence for calorie restriction’s longevity effect

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

Vitamin D deficiency increases risk of chronic headache

Get the Most From Your Green Tea

VIDEO: The Best Brain Foods That Help Increase Your Memory!

Acupuncture boosts effectiveness of standard medical care for chronic pain, depression

Iron (And More) For Lasting, Natural Energy

Metabolic syndrome increases the need for vitamin E

Supplement combo improves bone density, mood, in postmenopausal women

 
Print Page
Email Article

Study Shows COX-2 Inhibitor Is Effective Alternative to Morphine-Sparing Analgesics in Knee Replacement Surgery

  [ 27 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 15, 2002




The COX-2 inhibitor valdecoxib, has demonstrated effective post-operative pain relief and significantly reduced patient consumption of the opiate analgesic morphine, when administered post-operatively to patients undergoing knee replacement surgery. This is according to an investigational study presented at the annual meeting of the American Academy of Orthopedic Surgeons.

"Avoiding post-operative pain is a major priority, and a significant source of anxiety, for patients undergoing surgery," said principal investigator Lowell Reynolds, M.D., Medical Director, Loma Linda University. "We are encouraged by the results of this study as they suggest valdecoxib may be a viable alternative for treating post-surgical pain."

In this multicenter, double-blind study, 209 patients were randomized to receive valdecoxib (20 mg or 40 mg) or placebo as soon as they could tolerate oral medication following surgery, and subsequent doses at 12, 24, and 36 hours after the first dose or until discontinuation of morphine.

Morphine administration by a patient controlled analgesia (PCA) pump began following administration of study medication. Efficacy was assessed by measuring the total amount of morphine consumed over the first 24 and 48 hours following the first dose of valdecoxib.

Average consumption of morphine in the morphine plus placebo group was 69.5 mg on day one and 27.1 mg on day two. Patients who received valdecoxib 40 mg every 12 hours consumed 56.5 mg and 16.7 mg morphine on day one and day two, respectively. These figures represent significant reductions of 19 percent and 38 percent versus placebo on day one and two, respectively. Patients receiving valdecoxib 20 mg every 12 hours also consumed a lower total average amount of morphine versus placebo.

Although morphine consumption in the valdecoxib group was comparable to placebo on day one, patients in the valdecoxib group consumed significantly less morphine on day two than those in the placebo group.

Overall, during the 48 hours post surgery, morphine consumption by patients receiving valdecoxib every 12 hours was reduced by 16.3 percent and 24.2 percent, respectively, compared with those patients receiving morphine plus placebo.

Additionally, a higher percentage of patients treated with valdecoxib plus morphine described their study medication as "good" or "excellent," compared with 70 percent of patients receiving morphine plus placebo.

In addition, patients receiving valdecoxib plus morphine reported greater reductions in pain intensity than those receiving placebo, even though those patients consumed more morphine.

There were no significant differences in the incidence of most adverse events between treatment groups, but the incidence of fever was significantly higher among patients receiving morphine alone versus either group of patients receiving morphine plus valdecoxib.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ FibroSleep™ Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Itching to Find Dry Skin Relief? Itching to Find Dry Skin Relief?
Break Free From Fibromyalgia Break Free From Fibromyalgia
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
The Surprising Benefits of Probiotics - What You Didn't Know The Surprising Benefits of Probiotics - What You Didn't Know

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map